Trial Profile

A phase II clinical study of CSTC-1 for Diabetic Foot Ulcer

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 21 Feb 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

21 Feb 2022 According to a Charsire Biotechnology Corporation company website, on Aug 2014, this study was granted by the Ministry of Economic Affairs. ( link : http://charsire.com.tw/about_en.html )
21 Feb 2022 According to a Charsire Biotechnology Corporation company website, on April 2014, the drug was approved by the Taiwan FDA for this phase II clinical trial. ( link : http://charsire.com.tw/about_en.html )
21 Feb 2022 According to a Charsire Biotechnology Corporation company website, on July 2013, the drug was approved by the FDA to enter this phase II clinical trial. ( link : http://charsire.com.tw/about_en.html )

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com